Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity

Clinical and Experimental Medicine

Volumn 9, Issue 4, 2009, Pages 319-325

  Chen, Elizabeth Suchi ^a   Mazzotti, Diego Robles ^a   Furuya, Tatiane Katsue ^a   Cendoroglo, Maysa Seabra ^a   Ramos, Luiz Roberto ^a   Araujo, Lara Quirino ^a   Burbano, Rommel Rodriguez ^a   De Arruda Cardoso Smith, Marília ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

APOA1 polymorphisms; Glycated hemoglobin; Hypertension; Obesity

Indexed keywords

APOLIPOPROTEIN A1; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

AGED; ALBUMIN BLOOD LEVEL; ALLELE; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN A-I; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CHOLESTEROL; COHORT STUDIES; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TRIGLYCERIDES;

EID: 70349925223     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0051-3     Document Type: Article

References (54)

1. Prado RR, Nascimento AF, Souza MFM (2006) Brazil Health 2006: an analysis of the health situation in Brazil. Editora MS, Brasília
2. JE Hokanson MA Austin 1996 Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 213 219 8836866 10.1097/00043798-199604000-00014 1:STN:280: DyaK28vjtlyrtA%3D%3D
3. D Steinberg AM Gotto Jr 1999 Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside JAMA 282 2043 2050 10591387 10.1001/jama.282.21.2043 1:STN:280:DC%2BD3c%2Flslentg%3D%3D
4. S Eichenbaum-Voline M Olivier EL Jones RP Naoumova B Jones B Gau HN Patel M Seed DJ Betteridge DJ Galton EM Rubin J Scott CC Shoulders LA Pennacchio 2004 Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia Arterioscler Thromb Vasc Biol 24 167 174 14551155 10.1161/01.ATV.0000099881.83261.D4 1:CAS:528:DC%2BD3sXhtVWhurvJ (Pubitemid 38082429)
5. R Mar P Pajukanta H Allayee M Groenendijk G Dallinga-Thie RM Krauss JS Sinsheimer RM Cantor TW de Bruin AJ Lusis 2004 Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia Circ Res 94 993 999 15001527 10.1161/01.RES.0000124922.61830.F0 1:CAS:528:DC%2BD2cXivVKqsbw%3D (Pubitemid 38490078)
6. PJ Talmud E Hawe S Martin M Olivier GJ Miller EM Rubin LA Pennacchio SE Humphries 2002 Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides Hum Mol Genet 11 3039 3046 12417525 10.1093/hmg/11.24.3039 1:CAS:528:DC%2BD38XosFOgsL4%3D
7. S Garasto G Rose F Derango M Berardelli A Corsonello E Feraco V Mari R Maletta A Bruni C Franceschi L Carotenuto G De Benedictis 2003 The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects Ann Hum Genet 67 54 62 12556235 10.1046/j.1469-1809.2003.00008.x 1:CAS:528:DC%2BD3sXnslKmsrc%3D (Pubitemid 38312850)
8. KL Chien MF Chen HC Hsu TC Su WT Chang CM Lee YT Lee 2008 Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population Clin Chim Acta 388 78 83 17964293 10.1016/j.cca.2007.10.006 1:CAS:528:DC%2BD2sXhsVOltLfO (Pubitemid 350266570)
9. RA Srivastava N Srivastava 2000 High density lipoprotein, apolipoprotein A-I, and coronary artery disease Mol Cell Biochem 209 131 144 10942211 10.1023/A:1007111830472 1:CAS:528:DC%2BD3cXlt1Gmsb8%3D
10. JM Ordovas D Corella LA Cupples S Demissie A Kelleher O Coltell PW Wilson EJ Schaefer K Tucker 2002 Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study Am J Clin Nutr 75 38 46 11756058 1:CAS:528:DC%2BD38Xhslymsw%3D%3D
11. G Florvall S Basu A Larsson 2006 Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men J Gerontol A Biol Sci Med Sci 61 1262 1266 17234819
12. XL Wang RB Badenhop AS Sim DE Wilcken 1998 The effect on transcription efficiency of the apolipoprotein AI gene of DNA variants at the 5? untranslated region Int J Clin Lab Res 28 235 241 9879497 10.1007/s005990050051 1:CAS:528:DyaK1cXotFKku7w%3D (Pubitemid 29014842)
13. PJ Talmud S Ye SE Humphries 1994 Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study Genet Epidemiol 11 265 280 8088507 10.1002/gepi.1370110305 1:STN:280:DyaK2cznsVKmuw%3D%3D (Pubitemid 24184735)
14. MI Kamboh CE Aston CM Nestlerode AE McAllister RF Hamman 1996 Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol Atherosclerosis 127 255 262 9125316 10.1016/S0021-9150(96) 05966-7 1:CAS:528:DyaK28Xnt1Kls70%3D (Pubitemid 27045839)
15. A Pulkkinen L Viitanen A Kareinen S Lehto M Laakso 2000 MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease Diabetes Care 23 791 795 10840998 10.2337/diacare.23.6.791 1:CAS:528:DC%2BD3cXnvV2isL4%3D
16. S Chhabra R Narang R Lakshmy N Das 2005 APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among Northern Indians Dis Markers 21 169 174 16403951 1:CAS:528: DC%2BD28Xht1Cgug%3D%3D
17. S Morcillo F Cardona G Rojo-Martinez I Esteva MS Ruiz-de-Adana F Tinahones JM Gomez-Zumaquero F Soriguer 2005 Association between MspI polymorphism of the APO AI gene and type 2 diabetes mellitus Diabet Med 22 782 788 15910632 10.1111/j.1464-5491.2005.01514.x 1:CAS:528:DC%2BD2MXlvVGhtLs%3D (Pubitemid 40805902)
18. XL Wang R Badenhop KE Humphrey DE Wilcken 1995 C to T and/or G to A transitions are responsible for loss of a MspI restriction site at the 5?-end of the human apolipoprotein AI gene Hum Genet 95 473 474 7535747 10.1007/BF00208984 1:CAS:528:DyaK2MXmtVWlsLo%3D
19. XL Wang R Badenhop KE Humphrey DE Wilcken 1996 New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels Genet Epidemiol 13 1 10 8647374 10.1002/(SICI)1098-2272(1996)13:1<1::AID-GEPI1>3.0.CO;2-D (Pubitemid 26085369)
20. YQ Ma GN Thomas MC Ng JA Critchley CS Cockram JC Chan B Tomlinson 2003 Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes Clin Endocrinol (Oxf) 59 442 449 10.1046/j.1365-2265.2003.01865.x 1:CAS:528:DC%2BD3sXosFKqtbg%3D (Pubitemid 37188174)
21. LR Ramos J Toniolo MS Cendoroglo JT Garcia MS Najas M Perracini CR Paola FC Santos T Bilton SJ Ebel MB Macedo CM Almada F Nasri RD Miranda M Goncalves AL Santos R Fraietta I Vivacqua ML Alves ES Tudisco 1998 Two-year follow-up study of elderly residents in S Paulo, Brazil: methodology and preliminary results Rev Saude Publica 32 397 407 10030055 10.1590/S0034-89101998000500001 1:STN:280:DyaK1M7lsVehsQ%3D%3D
22. JA Whitworth 2003 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens 21 1983 1992 14597836 10.1097/00004872-200311000-00002 (Pubitemid 38296854)
23. DW Jones JE Hall 2004 Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials Hypertension 43 1 3 14676222 10.1161/01.HYP.0000110061.06674.ca 1:CAS:528:DC%2BD2cXptVGntw%3D%3D (Pubitemid 38031902)
24. (1999) Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe. Diabetologia 42:647-654
25. UG Kyle L Genton D Hans VL Karsegard JP Michel DO Slosman C Pichard 2001 Total body mass, fat mass, fat-free mass, and skeletal muscle in older people: cross-sectional differences in 60-year-old persons J Am Geriatr Soc 49 1633 1640 11843996 10.1111/j.1532-5415.2001.49272.x 1:STN:280:DC%2BD387htVGnug%3D%3D (Pubitemid 34007989)
26. MF Rolland-Cachera TJ Cole M Sempe J Tichet C Rossignol A Charraud 1991 Body Mass Index variations: centiles from birth to 87 years Eur J Clin Nutr 45 13 21 1855495 1:STN:280:DyaK3MzgvFKjsg%3D%3D
27. MF Folstein SE Folstein PR McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
28. PH Bertolucci SM Brucki SR Campacci Y Juliano 1994 The Mini-Mental State Examination in a general population: impact of educational status] Arq Neuropsiquiatr 52 1 7 8002795 1:STN:280:DyaK2c3ntV2qtQ%3D%3D
29. PH Bertolucci IH Okamoto SM Brucki MO Siviero J Toniolo Neto LR Ramos 2001 Applicability of the CERAD neuropsychological battery to Brazilian elderly Arq Neuropsiquiatr 59 532 536 11588630 1:STN:280:DC%2BD3MrjvFGntw%3D%3D
30. SL Blay LR Ramos J Mari Jde 1988 Validity of a Brazilian version of the Older Americans Resources and Services (OARS) mental health screening questionnaire J Am Geriatr Soc 36 687 692 3403873 1:STN:280:DyaL1c3pvFCntQ%3D%3D
31. TL Bush SR Miller AL Golden WE Hale 1989 Self-report and medical record report agreement of selected medical conditions in the elderly Am J Public Health 79 1554 1556 2817172 10.2105/AJPH.79.11.1554 1:STN:280: DyaK3c%2Fltl2htQ%3D%3D
32. Miller O (2003) Bioquímica do Sangue-Substâncias não-eletrolíticas. In: Miller O (2003) O Laboratório e os métodos de imagem para o clínico 5th edn. Editora Atheneu, São Paulo
33. ES Chen MS Cendoroglo LR Ramos LM Araujo GM Carvalheira RW de Labio RR Burbano SL Payao Smith MdAC 2006 APO A-V-1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population Clin Chem Lab Med 44 32 36 16375582 10.1515/CCLM.2006.007 1:CAS:528:DC%2BD28XhtlWrs70%3D (Pubitemid 43010642)
34. Emery AEH (1986) Methodology in medical genetics-an introduction to statistical methods. Longman, Edinburgh
35. X Sole E Guino J Valls R Iniesta V Moreno 2006 SNPStats: a web tool for the analysis of association studies Bioinformatics 22 1928 1929 16720584 10.1093/bioinformatics/btl268 1:CAS:528:DC%2BD28Xotl2qsLo%3D (Pubitemid 44283043)
36. MI Kamboh CH Bunker CE Aston CS Nestlerode AE McAllister FA Ukoli 1999 Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks Genet Epidemiol 16 205 222 10030402 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P 1:STN:280:DyaK1M7ltlCksQ%3D%3D (Pubitemid 29070265)
37. H Bai K Saku R Liu S Jimi K Arakawa 1996 Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease J Cardiol 28 207 212 8934336 1:STN:280: DyaK2s%2FovVequg%3D%3D
38. M Jeenah A Kessling N Miller S Humphries 1990 G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations Mol Biol Med 7 233 241 1977072 1:CAS:528:DyaK3cXlvVGrsL0%3D
39. G Sigurdsson Jr V Gudnason G Sigurdsson SE Humphries 1992 Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I Arterioscler Thromb 12 1017 1022 1525115 1:CAS:528:DyaK38Xmt1yhtLc%3D
40. A Minnich G DeLangavant J Lavigne G Roederer S Lussier-Cacan J Davignon 1995 G→A substitution at position -75 of the apolipoprotein A-I gene promoter. Evidence against a direct effect on HDL cholesterol levels Arterioscler Thromb Vasc Biol 15 1740 1745 7583551 1:CAS:528:DyaK2MXpsFahs7o%3D
41. E de Franca JG Alves MH Hutz 2005 APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children Braz J Med Biol Res 38 535 541 15962178 10.1590/S0100-879X2005000400006
42. JH Wu JT Kao MS Wen SK Lo 2000 DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index J Formos Med Assoc 99 367 374 10870325 1:CAS:528: DC%2BD3cXksVCgu7Y%3D
43. JR Reguero GI Cubero A Batalla V Alvarez S Hevia A Cortina E Coto 1998 Apolipoprotein A1 gene polymorphisms and risk of early coronary disease Cardiology 90 231 235 9892774 10.1159/000006849 1:STN:280:DyaK1M7htVOjsw%3D%3D (Pubitemid 29039148)
44. C Lahoz R Pena JM Mostaza J Jimenez E Subirats X Pinto M Taboada A Lopez-Pastor 2003 Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy Atherosclerosis 168 289 295 12801612 10.1016/S0021-9150(03)00094-7 1:CAS:528:DC%2BD3sXksVOkurk%3D (Pubitemid 36703328)
45. SA Al-Yahyaee MN Al-Kindi AI Al-Bahrani 2004 Apolipoprotein A1 gene polymorphisms at the -75 bp and +83/84 bp polymorphic sites in healthy Omanis compared with world populations Hum Biol 76 307 312 15359539 10.1353/hub.2004.0028
46. CK Heng PS Low N Saha 2001 Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore Pediatr Res 49 514 518 11264435 10.1203/00006450- 200104000-00013 1:CAS:528:DC%2BD3MXjtVyitbk%3D
47. YQ Ma GN Thomas B Tomlinson 2005 Association of two apolipoprotein A-I gene MspI polymorphisms with lipid and blood pressure levels Int J Cardiol 102 309 314 15982502 10.1016/j.ijcard.2004.10.017 (Pubitemid 40854048)
48. R Carnicer MA Navarro JM Arbones-Mainar C Arnal JC Surra S Acin A Sarria F Blanco-Vaca N Maeda J Osada 2007 Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia J Hypertens 25 1597 1607 17620955 10.1097/HJH. 0b013e3281ab6c3d 1:CAS:528:DC%2BD2sXnsVCrs78%3D (Pubitemid 47056565)
49. V Sathiyapriya N Selvaraj H Nandeesha Z Bobby A Agrawal P Pavithran 2007 Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxide levels in non-diabetic hypertensive subjects Arch Med Res 38 822 826 17923261 10.1016/j.arcmed.2007.05.008 1:CAS:528: DC%2BD2sXhtFehsL7N (Pubitemid 47513278)
50. N Barzilai AR Shuldiner 2001 Searching for human longevity genes: the future history of gerontology in the post-genomic era J Gerontol A Biol Sci Med Sci 56 M83 M87 11213281 1:STN:280:DC%2BD3M7jsVOktA%3D%3D
51. RM Touyz 2004 Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44 248 252 15262903 10.1161/01.HYP.0000138070.47616.9d 1:CAS:528: DC%2BD2cXmslOmtrc%3D (Pubitemid 39167216)
52. SK Jain M Palmer 1997 The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins Free Radic Biol Med 22 593 596 9013122 10.1016/S0891-5849(96)00377-2 1:CAS:528:DyaK2sXntlyiug%3D%3D (Pubitemid 27043396)
53. N Selvaraj Z Bobby V Sathiyapriya 2006 Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes Clin Chim Acta 366 190 195 16325165 10.1016/j.cca.2005.10.002 1:CAS:528:DC%2BD28XitVKhsbk%3D (Pubitemid 43330982)
54. WJ McCarthy AK Yancey JM Siegel WK Wong A Ward J Leslie E Gonzalez 2008 Correlation of obesity with elevated blood pressure among racial/ethnic minority children in two Los Angeles middle schools Prev Chronic Dis 5 A46 18341781